U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Methylprednisolone Acetate Injection
Status: Currently in Shortage
»Date first posted: 12/15/2021
»Therapeutic Categories: Rheumatology

Expand all

Amneal Pharmaceutical (New 12/15/2021)

Company Contact Information:
866-525-7270

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40mg/mL, 1 single-dose vial (NDC 70121-1573-01) Unavailable Increase in demand
40 mg/mL, 25 single-dose vials (NDC 70121-1573-05) Unavailable Increase in demand
80 mg/mL, 1 single-dose vials (NDC 70121-1574-01) Unavailable Increase in demand
80 mg/mL, 25 single-dose vials (NDC 70121-1574-05) Unavailable Increase in demand

Northstar (New 12/15/2021)

Company Contact Information:
972-446-4800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40mg/ml, 1ml/1 vial X 25 (NDC 16714-088-25) Available; Product on allocation Other
40mg/ml, 1ml/1 vial (NDC 16714-088-01) Available; Product on allocation Other
200mg/5ml (40mg/ml) (NDC 16714-089-01) Out of Stock Other
80mg/ml, 1ml/1 vial X 25 (NDC 16714-472-25) Available; Product on allocation Other
80mg/ml, 1ml/1 vial (NDC 16714-472-01) Available; Product on allocation Other
400mg/5ml (80mg/ml), 5ml/1 vial (NDC 16714-473-01) Available; Product on allocation Other
400mg/10ml (40mg/ml) (NDC 16714-090-01) Available; Product on allocation Other

Par Pharmaceutical, Inc. (New 06/16/2022)

Company Contact Information:
800-828-9393

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
400 mg/5 mL (80 mg/mL), 5 mL multiple dose vial, box of 1 (NDC 42023-240-01) Available

Pfizer Pharmaceuticals (Revised 09/12/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg/mL; Multidose Vial (NDC 0009-0274-01) Next Delivery and Estimated Recovery: December 2022 Other
40 mg/mL; Multidose Vial (NDC 0009-0280-02) Next Delivery and Estimated Recovery: November 2022 Shortage per Manufacturer: Manufacturing Delay Other
40 mg/mL; Multidose Vial (NDC 0009-0280-03) Limited Supply Next Delivery: September 2022; Estimated Recovery: October 2022 Demand increase for the drug
40 mg/mL; Multidose Vial (NDC 0009-0280-51) Next Delivery and Estimated Recovery: October 2022 Shortage per Manufacturer: Manufacturing Delay Other
40 mg/mL; Multidose Vial (NDC 0009-0280-52) Next Delivery and Estimated Recovery: October 2022 Shortage per Manufacturer: Manufacturing Delay Other
80 mg/mL; Multidose Vial (NDC 0009-0306-02) Available Other
80 mg/mL; Multidose Vial (NDC 0009-0306-12) Next Delivery and Estimated Recovery: September 2022 Shortage per Manufacturer: Manufacturing Delay Other
40 mg/mL; Single-dose Vial (NDC 0009-3073-01) Limited Supply Next Delivery: December 2022; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing Delay Other
40 mg/mL; Single-dose Vial (NDC 0009-3073-03) Next Delivery: September 2022; Estimated Recovery: December 2022 Demand increase for the drug
40 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3073-22) Next Delivery and Estimated Recovery: October 2022 Shortage per Manufacturer: Manufacturing Delay Other
80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3073-23) Next Delivery and Estimated Recovery: October 2022 Shortage per Manufacturer: Manufacturing Delay Other
80 mg/mL; Single-dose Vial (NDC 0009-3475-01) Next Delivery and Estimated Recovery: October 2022 Shortage per Manufacturer: Manufacturing Delay Other
80 mg/mL; Single-dose Vial (NDC 0009-3475-03) Next Delivery: September 2022; Estimated Recovery: July 2023 Demand increase for the drug
80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3475-22) Next Delivery and Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing Delay Other
80 mg/mL; Single-dose Vial NovaPlus (NDC 0009-3475-23) Next Delivery: February 2023; Estimated Recovery: July 2023 Shortage per Manufacturer: Manufacturing Delay Other

Sagent Pharmaceuticals (Reverified 08/22/2022)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40MG/ML 1X10ML (NDC 25021-820-010) Available
40MG/ML 1X5ML (NDC 25021-820-05) Backorder. Estimated availability June 2022
80MG/ML 1x5ML (NDC 25021-821-05) Available

Teva Pharmaceuticals (Reverified 10/05/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
400 mg/10 mL (40 mg/mL) 10 mL Multiple-Dose Vial (NDC 0703-0045-01) Backordered; Estimated duration TBD Other
400 mg/5 mL (80 mg/mL) 5 mL Multiple-Dose Vial(NDC 0703-0063-01) Backordered; Estimated duration TBD Other
200 mg/5 mL (40 mg/mL) 5 mL Multiple-Dose Vial(NDC 0703-0043-01) Backordered; Estimated duration TBD Other
40 mg/mL 1 mL Single-Dose Vial (NDC 0703-0031-01) Backordered; Estimated duration TBD Other
80 mg/mL 1 mL Single-Dose Vial(NDC 0703-0051-01) Backordered; Estimated duration TBD Other
40 mg/mL 25 x 1 mL Single-Dose Vial (NDC 0703-0031-04 40) Backordered; Estimated duration TBD Other
80 mg/mL 25 x 1 mL Single-Dose Vial(NDC 0703-0051-04) Backordered; Estimated duration TBD Other
Back to Top